Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Publications

Publications searcher

The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points.

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.

PMID: 36324795
Journal:
Year: 2022
Reference: medRxiv. 2022 Oct 25. doi: 10.1101/2022.10.22.22281221.
Impact factor:
Publication type: Letter or abstract
Authors: Abel, Laurent; Abolhassani, Hassan; Aiuti, Alessandro; Akcan, Ozge Metin; Al-Muhsen, Saleh Zaid; Allende, Luis M; Alonso-Arias, Rebeca; Arias, Andres Augusto; Asano, Takaki; Aytekin, Gokhan et al.
DOI: 10.1101/2022.10.22.22281221

Rates of Response to Atogepant for Migraine Prophylaxis Among Adults: A Secondary Analysis of a Randomized Clinical Trial.

PMID: 35675076
Journal: JAMA Network Open
Year: 2022
Reference: JAMA Netw Open. 2022 Jun 1;5(6):e2215499. doi: 10.1001/jamanetworkopen.2022.15499.
Impact factor: 8.485
Publication type: Paper in international publication
Authors: Li, Ye, Lu, Kaifeng, Lipton, Richard B, Pozo-Rosich, Patricia, Blumenfeld, Andrew M, Dodick, David W, McAllister, Peter, Miceli, Rosa, Trugman, Joel M, Finnegan, Michelle et al.
DOI: 10.1001/jamanetworkopen.2022.15499

Rates of Response to Atogepant for Migraine Prophylaxis Among Adults: A Secondary Analysis of a Randomized Clinical Trial.

PMID: 35675076
Journal: JAMA Network Open
Year: 2022
Reference: JAMA Netw Open. 2022 Jun 1;5(6):e2215499. doi: 10.1001/jamanetworkopen.2022.15499.
Impact factor:
Publication type: Paper in international publication
Authors: Blumenfeld, Andrew M; Dabruzzo, Brett; Dodick, David W; Finnegan, Michelle; Li, Ye; Lipton, Richard B; Lu, Kaifeng; McAllister, Peter; Miceli, Rosa; Pozo-Rosich, Patricia et al.
DOI: 10.1001/jamanetworkopen.2022.15499

Rationale and design of the AXIOMATIC-SSP phase II trial: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke Prevention.

PMID: 36037679
Journal: Journal of Stroke & Cerebrovascular Diseases
Year: 2022
Reference: J Stroke Cerebrovasc Dis. 2022 Oct;31(10):106742. doi: 10.1016/j.jstrokecerebrovasdis.2022.106742. Epub 2022 Aug 27.
Impact factor:
Publication type: Paper in international publication
Authors: Amarenco, Pierre; Bereczki, Daniel; Czlonkowska, Anna; Diener, Hans Christoph; Donovan, Mark; Endres, Matthias; Gailani, David; Hankey, Graeme J; Kahl, Anja; Kasner, Scott E et al.
DOI: 10.1016/j.jstrokecerebrovasdis.2022.106742

Rationale and design of the PeriOperative ISchemic Evaluation-3 (POISE-3): a randomized controlled trial evaluating tranexamic acid and a strategy to minimize hypotension in noncardiac surgery.

PMID: 35101083
Journal: Trials
Year: 2022
Reference: Trials. 2022 Jan 31;23(1):101. doi: 10.1186/s13063-021-05992-1.
Impact factor: 2.279
Publication type: Paper in international publication
Authors: Ofori, Sandra N, Marcucci, Maura, Painter, Thomas W, Conen, David, Leslie, Kate, Lomivorotov, Vladimir V, Sessler, Daniel, Chan, Matthew T V, Borges, Flavia K, Martinez Zapata, Maria J et al.
DOI: 10.1186/s13063-021-05992-1

Rationale and design of the PeriOperative ISchemic Evaluation-3 (POISE-3): a randomized controlled trial evaluating tranexamic acid and a strategy to minimize hypotension in noncardiac surgery.

PMID: 35101083
Journal: Trials
Year: 2022
Reference: Trials. 2022 Jan 31;23(1):101. doi: 10.1186/s13063-021-05992-1.
Impact factor:
Publication type: Paper in international publication
Authors: Abubakirov, Marat; Aguado, Hector J; Alfonsi, Pascal; Amir, Mohammed; Astrakov, Sergey V; Ayad, Sabry; Balasubramanian, Kumar; Bangdiwala, Shrikant I; Belley-Cote, Emily; Bhatt, Keyur et al.
DOI: 10.1186/s13063-021-05992-1

Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT).

PMID: 34351426
Journal: European Heart Journal-Cardiovascular Pharmacotherapy
Year: 2022
Reference: Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):291-301. doi: 10.1093/ehjcvp/pvab060.
Impact factor: 6.617
Publication type: Letter or abstract
Authors: Rossello, Xavier, Dominguez-Rodriguez, Alberto, Barrabes, Jose A, Sanchez, Pedro L, Anguita, Manuel, Fernandez-Vazquez, Felipe, Pascual-Figal, Domingo, De la Torre Hernandez, Jose M, Ferraro, Stefano, Vetrano, Alfredo et al.
DOI: 10.1093/ehjcvp/pvab060

Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT).

PMID: 34351426
Journal: European Heart Journal-Cardiovascular Pharmacotherapy
Year: 2022
Reference: Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):291-301. doi: 10.1093/ehjcvp/pvab060.
Impact factor:
Publication type: Letter or abstract
Authors: Aguero, Jaume; Anguita, Manuel; Barrabes, Jose A; De la Torre Hernandez, Jose M; Dominguez-Rodriguez, Alberto; Escalera, Noemi; Fernandez-Vazquez, Felipe; Ferraro, Stefano; Fuster, Valentin; Ibanez, Borja et al.
DOI: 10.1093/ehjcvp/pvab060

Re: Magdalena Gortz, Jan Philipp Radtke, Gencay Hatiboglu, et al. The Value of Prostate-specific Antigen Density for Prostate Imaging-Reporting and Data System 3 Lesions on Multiparametric Magnetic Resonance Imaging: A Strategy to Avoid Unnecessary Prostate Biopsies. Eur Urol Focus 2021;7:325-31.

PMID: 34992001
Journal: European Urology Focus
Year: 2022
Reference: Eur Urol Focus. 2022 Jan 3. pii: S2405-4569(21)00318-7. doi: 10.1016/j.euf.2021.12.007.
Impact factor: 5.996
Publication type: Letter or abstract
Authors: Morote, Juan, Planas, Jacques, Trilla, Enrique et al.
DOI: 10.1016/j.euf.2021.12.007

Re: Magdalena Gortz, Jan Philipp Radtke, Gencay Hatiboglu, et al. The Value of Prostate-specific Antigen Density for Prostate Imaging-Reporting and Data System 3 Lesions on Multiparametric Magnetic Resonance Imaging: A Strategy to Avoid Unnecessary Prostate Biopsies. Eur Urol Focus 2021;7:325-31.

PMID: 34992001
Journal: European Urology Focus
Year: 2022
Reference: Eur Urol Focus. 2022 Sep;8(5):1557-1558. doi: 10.1016/j.euf.2021.12.007. Epub 2022 Jan 3.
Impact factor:
Publication type: Letter or abstract
Authors: Morote, Juan; Planas, Jacques; Trilla, Enrique et al.
DOI: 10.1016/j.euf.2021.12.007

Reaching a consensus on the definition of "difficult" cholecystectomy among Spanish experts. A Delphi project. A qualitative study.

PMID: 35525412
Journal: International Journal of Surgery
Year: 2022
Reference: Int J Surg. 2022 Jun;102:106649. doi: 10.1016/j.ijsu.2022.106649. Epub 2022 May 4.
Impact factor: 6.071
Publication type: Paper in international publication
Authors: Latorre-Fragua, Raquel, Alcazar, Candido, Requena, Paola Melgar, de la Plaza, Roberto, Blanco Fernandez, Gerardo, Serradilla-Martin, Mario, Ramia, J M, Cudrado, Martin Bailon, Blas Laina, Juan Luis, Suescun, Federico Castillo et al.
DOI: 10.1016/j.ijsu.2022.106649

Reaching a consensus on the definition of "difficult" cholecystectomy among Spanish experts. A Delphi project. A qualitative study.

PMID: 35525412
Journal: International Journal of Surgery
Year: 2022
Reference: Int J Surg. 2022 Jun;102:106649. doi: 10.1016/j.ijsu.2022.106649. Epub 2022 May 4.
Impact factor:
Publication type: Paper in international publication
Authors: Alcazar, Candido; Andorra, Estaban Cugat; Azagra, Santiago; Ben, Santiago Lopez; Blanco Fernandez, Gerardo; Blas Laina, Juan Luis; Cecilia, David Martinez; Conde, Salvador Morales; Cruchaga, Pablo Marti; Cudrado, Martin Bailon et al.
DOI: 10.1016/j.ijsu.2022.106649

REACT Aspiration Catheters: Clinical Experience and Technical Considerations.

PMID: 35718472
Journal: Neurointervention
Year: 2022
Reference: Neurointervention. 2022 Jul;17(2):70-77. doi: 10.5469/neuroint.2022.00255. Epub 2022 Jun 20.
Impact factor: 0
Publication type: Review in international publication
Authors: Li, Jiahui; Ribo, Marc et al.
DOI: 10.5469/neuroint.2022.00255

REACT Aspiration Catheters: Clinical Experience and Technical Considerations.

PMID: 35718472
Journal: Neurointervention
Year: 2022
Reference: Neurointervention. 2022 Jul;17(2):70-77. doi: 10.5469/neuroint.2022.00255. Epub 2022 Jun 20.
Impact factor:
Publication type: Review in international publication
Authors: Li, Jiahui; Li, Jiahui; Ribo, Marc et al.
DOI: 10.5469/neuroint.2022.00255

Reactogenicity to the mRNA-1273 Booster According to Previous mRNA COVID-19 Vaccination.

PMID: 36016105
Journal: Vaccines
Year: 2022
Reference: Vaccines (Basel). 2022 Jul 29;10(8). pii: vaccines10081217. doi: 10.3390/vaccines10081217.
Impact factor:
Publication type: Paper in international publication
Authors: Aguilera, Cristina; Agusti, Antonia; Armadans, Lluis; Borras-Bermejo, Blanca; Campins, Magda; Cossio-Gil, Yolima; Martinez-Gomez, Xavier; Otero, Susana; Pares-Badell, Oleguer; Pinos, Laia et al.
DOI: 10.3390/vaccines10081217

Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study).

PMID: 35475683
Journal: Microbiology Spectrum
Year: 2022
Reference: Microbiol Spectr. 2022 Jun 29;10(3):e0229221. doi: 10.1128/spectrum.02292-21. Epub 2022 Apr 27.
Impact factor: 7.171
Publication type: Paper in international publication
Authors: Ruiz-Camps, Isabel, Bergas, Alba, Albasanz-Puig, Adaia, Fernandez-Cruz, Ana, Machado, Marina, Novo, Andres, van Duin, David, Garcia-Vidal, Carolina, Hakki, Morgan, Gudiol, Carlota et al.
DOI: 10.1128/spectrum.02292-21

Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study).

PMID: 35475683
Journal: Microbiology Spectrum
Year: 2022
Reference: Microbiol Spectr. 2022 Jun 29;10(3):e0229221. doi: 10.1128/spectrum.02292-21. Epub 2022 Apr 27.
Impact factor:
Publication type: Paper in international publication
Authors: Aguilar-Company, Juan; Albasanz-Puig, Adaia; Alvarez-Uria, Ana; Bergas, Alba; Capilla, Silvia; Carmona-Torre, Francisco; Carratala, Jordi; Castaldo, Nadia; Clerici, Teresa Daniela; Del Pozo, Jose Luis et al.
DOI: 10.1128/spectrum.02292-21

[Real-life WAKE study in narcolepsy patients with cataplexy treated with pitolisant and unresponsive to previous treatments].

PMID: 36169322
Journal: REVISTA DE NEUROLOGIA
Year: 2022
Reference: Rev Neurol. 2022 Oct 1;75(7):165-171. doi: 10.33588/rn.7507.2022090.
Impact factor:
Publication type: Paper in national publication
Authors: Del Rio-Villegas, R; Gaig-Ventura, C; Gomez-Barrera, M; Martinez-Orozco, F J; Romero-Santo Tomas, O; Yebenes-Cortes, M et al.
DOI: 10.33588/rn.7507.2022090

Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea.

PMID: 35417564
Journal: CANCER
Year: 2022
Reference: Cancer. 2022 Jul 1;128(13):2441-2448. doi: 10.1002/cncr.34195. Epub 2022 Apr 13.
Impact factor: 6.86
Publication type: Paper in international publication
Authors: Gasior, Mercedes, Alvarez-Larran, Alberto, Garrote, Marta, Ferrer-Marin, Francisca, Perez-Encinas, Manuel, Mata-Vazquez, M Isabel, Bellosillo, Beatriz, Arellano-Rodrigo, Eduardo, Gomez, Montse, Garcia, Regina et al.
DOI: 10.1002/cncr.34195

Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea.

PMID: 35417564
Journal: CANCER
Year: 2022
Reference: Cancer. 2022 Jul 1;128(13):2441-2448. doi: 10.1002/cncr.34195. Epub 2022 Apr 13.
Impact factor:
Publication type: Paper in international publication
Authors: Alvarez-Larran, Alberto; Angona, Anna; Arellano-Rodrigo, Eduardo; Ayala, Rosa; Bellosillo, Beatriz; Caballero, Gonzalo; Carreno-Tarragona, Gonzalo; Cuevas, Beatriz; Del Orbe-Barreto, Rafael; Ferrer-Marin, Francisca et al.
DOI: 10.1002/cncr.34195

Real-world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities.

PMID: 36434742
Journal: Clinical and Translational Allergy
Year: 2022
Reference: Clin Transl Allergy. 2022 Nov;12(11):e12208. doi: 10.1002/clt2.12208.
Impact factor:
Publication type: Paper in international publication
Authors: Agache, Ioana; Amaral, Rita; Ansotegui, Ignacio J; Anto, Aram; Anto, Josep M; Bastl, Katharina; Bedbrook, Anna; Berger, Markus; Berger, Uwe; Bergmann, Karl C et al.
DOI: 10.1002/clt2.12208

Real-world data with the use of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura: A single-center with homogeneous treatment experience.

PMID: 36151933
Journal: TRANSFUSION
Year: 2022
Reference: Transfusion. 2022 Nov;62(11):2363-2369. doi: 10.1111/trf.17111. Epub 2022 Sep 24.
Impact factor:
Publication type: Paper in international publication
Authors: Bobillo, Sabela; Bosch, Francesc; Jimenez, Moraima; Miranda, Nayibe; Molero, Antonieta; Perez, Ana; Pons, Veronica; Sanchez, Angela; Sanchez, Carla; Tabares, Elizabeth et al.
DOI: 10.1111/trf.17111

Real-world effectiveness of caplacizumab vs standard of care in immune thrombotic thrombocytopenic purpura.

PMID: 35930694
Journal: Blood Advances
Year: 2022
Reference: Blood Adv. 2022 Dec 27;6(24):6219-6227. doi: 10.1182/bloodadvances.2022008028.
Impact factor:
Publication type: Paper in international publication
Authors: Atucha, Jon Ander; Avila Idrovo, Laura Francisca; Campuzano Saavedra, Veronica; Cid, Joan; Cruz, Naylen; de la Rubia, Javier; Del Rio-Garma, Julio; Fernandez Zarzoso, Miguel; Fernandez-Docampp, Marta; Freiria, Carmen et al.
DOI: 10.1182/bloodadvances.2022008028

Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma.

PMID: 35271707
Journal: Blood Advances
Year: 2022
Reference: Blood Adv. 2022 Jun 28;6(12):3606-3610. doi: 10.1182/bloodadvances.2021006922.
Impact factor: 6.799
Publication type: Letter whit IF
Authors: Reguera-Ortega, Juan Luis, Camacho-Arteaga, Lina, Schmidt, Christian, Marin-Niebla, Ana, Kersten, Marie Jose, Martin Garcia-Sancho, Alejandro, Zinzani, Pier Luigi, Corradini, Paolo, van Meerten, Tom, Subklewe, Marion et al.
DOI: 10.1182/bloodadvances.2021006922